ClinicalTrials.Veeva

Menu

Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer

Fred Hutchinson Cancer Center (FHCC) logo

Fred Hutchinson Cancer Center (FHCC)

Status

Active, not recruiting

Conditions

Metastatic Malignant Solid Neoplasm
Hematopoietic and Lymphoid System Neoplasm
Locally Advanced Malignant Solid Neoplasm

Treatments

Other: Questionnaire Administration
Other: Best Practice
Other: Internet-Based Intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05564468
NCI-2024-03279 (Registry Identifier)
20230 (Other Identifier)
RG1123556
R44NR020341 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This clinical trial examines a web-based tool, in partnership with Peacefully, Inc, designed to improve end-of-life planning among patients with advanced cancers. This program helps users prepare comprehensively for end-of-life (e.g., medical wishes, legal estate planning, financial planning and transfer of accounts, legacy building, and emotional support). It is expected that this web-based end-of-life planning program may reduce distress and improve end-of-life preparation among advanced cancer patients.

Full description

OUTLINE:

Patients are randomized to 1 of 2 groups and their engagement in end-of-life planning is assessed at baseline and four weeks post-randomization.

Group I (intervention): Patients receive Peacefully's web-based tool to help with end-of-life planning on day 7.

Group II (control): Patients receive standard of care.

After completion of study, patients are followed up at 4, 12, and 24 weeks post-randomization.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of poor prognosis advanced cancer defined as locally advanced or metastatic cancer and/or disease progression following at least first line systemic therapy
  • Access to a computer or mobile device
  • The ability to provide informed consent

Exclusion criteria

  • Not fluent in English
  • Severely cognitively impaired (as measured by Short Portable Mental Status Questionnaire scores of < 6)
  • Too ill or weak to complete the interviews (as judged by the interviewer)

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups

Group I (Peacefully's)
Experimental group
Description:
Patients receive Peacefully's web-based tool to help with end-of-life planning on day 7.
Treatment:
Other: Internet-Based Intervention
Other: Questionnaire Administration
Group II (standard of care)
Active Comparator group
Description:
Patients receive standard care.
Treatment:
Other: Best Practice
Other: Questionnaire Administration

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Megan J. Shen

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems